Discovery in toxicology: Mediation by gene expression array technology

Journal of Biochemical and Molecular Toxicology

Volumn 15, Issue 5, 2001, Pages 231-242

  Hamadeh, Hisham K ^a   Bushel, Pierre ^a   Paules, Richard ^a   Afshari, Cynthia A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Bioinformatics; Biomarkers; cDNA; Gene expression; Genomics; Microarrays; Pattern recognition; Single nucleotide polymorphisms; Toxicogenomics; Toxicology

Indexed keywords

BIOCHEMICAL MARKER; TOXIC SUBSTANCE;

ANIMAL CELL; CELL POPULATION; CONTROLLED STUDY; DATA BASE; DNA MICROARRAY; DRUG MECHANISM; EXPOSURE; GENE EXPRESSION; GENE TECHNOLOGY; GENETIC PROCEDURES; GENETIC TOXICOLOGY; HEALTH HAZARD; HYPOTHESIS; INFORMATION PROCESSING; INFORMATION SYSTEM; NONHUMAN; RAT; RISK ASSESSMENT; RNA TRANSCRIPTION; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; STATISTICAL ANALYSIS; TOXICOLOGY;

ANIMALS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, GENETIC; RISK ASSESSMENT; TOXICOLOGY;

EID: 0035190398     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.10006     Document Type: Short Survey

References (74)

1. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
2. High density synthetic oligonucleotide arrays
3. Light-directed, spatially addressable parallel chemical synthesis
4. A general method for the spatially defined immobilization of biomolecules on glass surfaces using "caged" biotin
5. MAPS: A microarray project system for gene expression experiment information and data validation
6. Data management and analysis for gene expression arrays
7. A gene expression database for the molecular pharmacology of cancer
8. Ratio-based decisions and the quantitative analysis of cDNA microarray images
9. Searching for evidence of altered gene expression: A comment on statistical analysis of microarray data
10. Importance of replication in microarray gene expression studies: Statistical methods and evidence from repetitive cDNA hybridizations
11. Assessing gene significance from cDNA microarray expression data via mixed models
12. Widespread aneuploidy revealed by DNA microarray expression profiling
13. Cluster analysis and display of genome-wide expression patterns
14. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
15. Gene assessment and sample classification for gene expression data using a genetic algorithm/k-nearest neighbor method
16. Prediction of compound signature using high density gene expression profiling
17. The transcriptional program in the response of human fibroblasts to serum
18. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles
19. The genetic program of hematopoietic stem cells
20. Drug target validation and identification of secondary drug target effects using DNA microarrays
21. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation
22. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization
23. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray
24. Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903 (+6), and SRS3 by comparison of expression profiles
25. Expression profiling of pancreatic beta cells: Glucose regulation of secretory and metabolic pathway genes
26. Altered patterns of gene expression in response to myocardial infarction
27. Genetic dissection of c-myc apoptotic pathways
28. Genome-wide characterization of the Zap1p zinc-responsive regulon in yeast
29. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons
30. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
31. Concise review: Gene expression applied to toxicology
32. Development of a toxicological gene array and quantitative assessment of this technology
33. Microarrays and toxicology: The advent of toxicogenomics
34. Application of DNA arrays to toxicology
35. Use of cDNA microarrays to probe and understand the toxicological consequences of altered gene expression
36. The impact of genomics-based technologies on drug safety evaluation
37. Revolution through genomics in investigative and discovery toxicology
38. cDNA microarray technology: Merging toxicology and genomics
39. Subtraction hybridisation and shot-gun sequencing: A new approach to identify symbiotic loci
40. Physical mapping of the human genome: On the way to developing an optimal strategy
41. Shot-gun sequencing strategy for long-range genome mapping: A pilot study
42. Mixed function oxidation and intermediary metabolism: Metabolic interdependencies in the liver
43. Progress in the application of DNA microarrays
44. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays
45. Detection of mutations and DNA polymorphisms using whole genome Southern Cross hybridization
46. Long-extension PCR to detect deleted mitochondrial DNA molecules is compromized by technical artefacts
47. The essence of SNPs
48. The use of single-nucleotide polymorphism maps in pharmacogenomics
49. Genetic susceptibility to lead poisoning
50. Polymorphism in drug metabolism-implications for drug toxicity
51. Molecular basis for differences in susceptibility to toxicants: Introduction
52. Combined genetic polymorphism and risk for development of lung cancer
53. Interactions between genetic predisposition and environmental toxicants for development of lung cancer
54. Human cytochrome P4501A2
55. Aneugenic effect of sodium arsenite on human lymphocytes in vitro: An individual susceptibility effect detected
56. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity
57. Variation in arsenic-induced sister chromatid exchange in human lymphocytes and lymphoblastoid cell lines
58. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan
59. Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells
60. A novel procedure for efficient genotyping of single nucleotide polymorphisms
61. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis
62. Genomic profiling of drug sensitivities via induced haploinsufficiency
63. Pharmacogenomics: Translating functional genomics into rational therapeutics
64. Pharmacogenomics: A new approach to individual therapy of hypertension?
65. Pharmacogenomics and the changing face of clinical Pharmacology
66. Proteome profiling-pitfalls and progress
67. Protein identification methods in proteomics
68. Proteomics to study genes and genomes
69. Cancer risk assessment and prevention: Where do we stand?
70. The road to embryologically based dose-response models
71. Selection of reproductive health end points for environmental risk assessment
72. Addressing human variability in risk assessment-the robustness of the intraspecies uncertainty factor
73. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells